209 related articles for article (PubMed ID: 10608414)
1. Pharmacokinetics and tissue distribution in animals of gadobenate ion, the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine 0.5 M solution for injection (MultiHance).
Lorusso V; Arbughi T; Tirone P; de Haën C
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S181-94. PubMed ID: 10608414
[TBL] [Abstract][Full Text] [Related]
2. Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis?
Kirchin MA; Lorusso V; Pirovano G
Br J Radiol; 2015 Apr; 88(1048):20140526. PubMed ID: 25651409
[TBL] [Abstract][Full Text] [Related]
3. Hepatic transport of the magnetic resonance imaging contrast agent gadobenate dimeglumine in the rat.
de Haën C; Lorusso V; Luzzani F; Tirone P
Acad Radiol; 1995 Mar; 2(3):232-8. PubMed ID: 9419554
[TBL] [Abstract][Full Text] [Related]
4. Toxicological safety evaluation of gadobenate dimeglumine 0.5 M solution for injection (MultiHance), a new magnetic resonance imaging contrast medium.
Morisetti A; Bussi S; Tirone P; de Haën C
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S207-17. PubMed ID: 10608416
[TBL] [Abstract][Full Text] [Related]
5. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals.
de Haën C; La Ferla R; Maggioni F
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S169-79. PubMed ID: 10608413
[TBL] [Abstract][Full Text] [Related]
6. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers.
Spinazzi A; Lorusso V; Pirovano G; Kirchin M
Acad Radiol; 1999 May; 6(5):282-91. PubMed ID: 10228617
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic determination of the magnetic resonance imaging contrast agent gadobenate ion in plasma, urine, faeces, bile and tissues.
Arbughi T; Bertani F; Celeste R; Grotti A; Sillari S; Tirone P
J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):415-26. PubMed ID: 9746258
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
[TBL] [Abstract][Full Text] [Related]
9. General pharmacology in experimental animals of gadobenate dimeglumine (MultiHance), a new magnetic resonance imaging contrast agent.
Tirone P; Castano M; Cipolla P; Frigeni V; La Noce A; Luzzani F; Valenti R; de Haën C
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S195-206. PubMed ID: 10608415
[TBL] [Abstract][Full Text] [Related]
10. Comparative study between gadobenate dimeglumine and gadobutrol in rats with brain ischemia: evaluation of somatosensory evoked potentials.
Frigeni V; Miragoli L; Grotti And A; Lorusso V
Invest Radiol; 2001 Oct; 36(10):561-72. PubMed ID: 11577266
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
Strzeminska I; Factor C; Robert P; Grindel AL; Comby PO; Szpunar J; Corot C; Lobinski R
Invest Radiol; 2020 Mar; 55(3):138-143. PubMed ID: 31917763
[TBL] [Abstract][Full Text] [Related]
12. Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment.
Swan SK; Lambrecht LJ; Townsend R; Davies BE; McCloud S; Parker JR; Bensel K; LaFrance ND
Invest Radiol; 1999 Jul; 34(7):443-8. PubMed ID: 10399633
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and safety of gadobenate dimeglumine (multihance) in subjects with impaired liver function.
Davies BE; Kirchin MA; Bensel K; Lorusso V; Davies A; Parker JR; Lafrance ND
Invest Radiol; 2002 May; 37(5):299-308. PubMed ID: 11979156
[TBL] [Abstract][Full Text] [Related]
14. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium.
de Haën C; Cabrini M; Akhnana L; Ratti D; Calabi L; Gozzini L
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S161-8. PubMed ID: 10608412
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic assay of the magnetic resonance imaging contrast agent gadobenate in plasma, urine and bile.
Lorusso V; Poggesi I; Arbughi T; Dal Fiume D; Tirone P
J Chromatogr B Biomed Appl; 1994 Jun; 656(2):415-22. PubMed ID: 7987495
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation.
Pastor CM; Planchamp C; Pochon S; Lorusso V; Montet X; Mayer J; Terrier F; Vallee JP
Radiology; 2003 Oct; 229(1):119-25. PubMed ID: 12944603
[TBL] [Abstract][Full Text] [Related]
17. A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (Gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology.
Runge VM; Armstrong MR; Barr RG; Berger BL; Czervionke LF; Gonzalez CF; Halford HH; Kanal E; Kuhn MJ; Levin JM; Low RN; Tanenbaum LN; Wang AM; Wong W; Yuh WT; Zoarski GH
Invest Radiol; 2001 Feb; 36(2):65-71. PubMed ID: 11224753
[TBL] [Abstract][Full Text] [Related]
18. Neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia: EEG evaluation.
La Noce A; Frigeni V; Demicheli F; Miragoli L; Tirone P
Invest Radiol; 1999 Apr; 34(4):262-7. PubMed ID: 10196717
[TBL] [Abstract][Full Text] [Related]
19. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.
Johansson L; Kirchin MA; Ahlström H
Acta Radiol; 2012 Dec; 53(10):1112-7. PubMed ID: 23081961
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
